Johnson&Johnson's MRI-safe indication for Cypher:
This article was originally published in Clinica
Executive Summary
Johnson & Johnson has received for its drug-eluting stent, Cypher, US FDA approval for MRI to be performed on patients immediately following the device's implantation. Cypher recipients typically had to wait for two months post device implantation before being scanned. Undergoing a scan sooner further enhances the overall level and quality of health care for stent patients, said the company. The FDA's decision comes just weeks after it granted a similar approval to Boston Scientific for its drug-eluting stent, Taxus.